Oliver Kiddie – Managing Director – Legend Mining (ASX:LEG) is an Australian exploration company listed on the Australian Securities Exchange (ASX:LEG). Legend’s mission is to make value-adding mineral discoveries and utilise all available asset bases to maximise stakeholder benefit.
Copyright 2024 – Finance News Network
Source: Finance News Network
31 May 2023 - Ron Mitchell, Managing Director of Global Lithium Resources Limited (ASX:GL1), which owns two of the 14 lithium resources in Australia, discusses the price of lithium and progress on the company's projects.
Read More13 Apr 2023 - Newmark Capital Managing Director Chris Langford discusses the group's portfolio, investment philosophy, results, strategy, the recent share buyback, and the outlook for the REIT sector.
Read More28 May 2021 - Beston Global Foods Limited (ASX:BFC) CFO and Acting CEO Darren Flew discusses the company's FY21 results, guidance and strategy, and provides an update on the company's lactoferrin expansion project at its Jervois dairy in South Australia.
Read More27 June 2025 - A look at The Perth Mint's services and investment offerings, from bullion to ASX-listed products.
Read More19 Feb 2020 - BluGlass (ASX:BLG) Managing Director, Giles Bourne talks about the opportunities that laser diodes represent for the company, following the Photonics West Conference.
Read More16 Aug 2023 - Dr John Melki - CEO and Director - Genetic Signatures (ASX:GSS) is transforming molecular diagnostics via streamlined sample processing methods linked to highly multiplexed real-time PCR screening assays.
Read More18 May 2022 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari provides an update on the company's pipeline and discusses the recent licensing of an asset from UCLA.
Read More29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
Read More02 June 2025 - Tariff shocks, central bank inertia, defensive positioning.
Read More19 Sep 2019 - Recce Pharmaceuticals Limited (ASX:RCE) Executive Director, James Graham provides an update on the company's lead product RECCE 327, including its progress with manufacturing, securing patents and presenting to a global audience.
Read More
